Jupiter Neurosciences Statistics
Total Valuation
JUNS has a market cap or net worth of $35.75 million. The enterprise value is $33.25 million.
| Market Cap | 35.75M |
| Enterprise Value | 33.25M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025, before market open.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
JUNS has 33.10 million shares outstanding. The number of shares has increased by 15.07% in one year.
| Current Share Class | 33.10M |
| Shares Outstanding | 33.10M |
| Shares Change (YoY) | +15.07% |
| Shares Change (QoQ) | +4.62% |
| Owned by Insiders (%) | 54.18% |
| Owned by Institutions (%) | 1.17% |
| Float | 15.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 11.67 |
| P/TBV Ratio | 11.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.91 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.08 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -99.87% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -132.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$833,598 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 52.88 |
| Average Volume (20 Days) | 700,583 |
Short Selling Information
The latest short interest is 284,456, so 0.86% of the outstanding shares have been sold short.
| Short Interest | 284,456 |
| Short Previous Month | 100,195 |
| Short % of Shares Out | 0.86% |
| Short % of Float | 1.88% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -860,738 |
| Operating Income | -4.06M |
| Pretax Income | n/a |
| Net Income | -3.33M |
| EBITDA | n/a |
| EBIT | -4.06M |
| Earnings Per Share (EPS) | -$0.11 |
Balance Sheet
The company has $2.71 million in cash and $205,495 in debt, giving a net cash position of $2.50 million or $0.08 per share.
| Cash & Cash Equivalents | 2.71M |
| Total Debt | 205,495 |
| Net Cash | 2.50M |
| Net Cash Per Share | $0.08 |
| Equity (Book Value) | 3.06M |
| Book Value Per Share | 0.09 |
| Working Capital | 1.72M |
Cash Flow
| Operating Cash Flow | -4.91M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
JUNS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.07% |
| Shareholder Yield | -15.07% |
| Earnings Yield | -9.33% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |